XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 3,160 $ 2,592
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation and amortization 219 208
Noncash lease expense 64 77
Stock-based compensation 355 323
Deferred income tax expense (benefit) (80) 58
Other investment (gains) (59) 0
Net (gains) losses within CIPs (170) (167)
Net (purchases) proceeds within CIPs (1,452) (947)
(Earnings) losses from equity method investees (92) (191)
Distributions of earnings from equity method investees 26 18
Changes in operating assets and liabilities:    
Accounts receivable (100) (472)
Investments, trading (40) 12
Other assets (1,064) (2,337)
Accrued compensation and benefits (948) (875)
Accounts payable and accrued liabilities 96 (110)
Other liabilities 1,042 2,402
Net cash provided by/(used in) operating activities 957 591 Close
Investing activities    
Purchases of investments (517) (584)
Proceeds from sales and maturities of investments 520 179
Distributions of capital from equity method investees 317 17
Net consolidations (deconsolidations) of sponsored investment funds (34) 27
Acquisition, net of cash acquired (74) 0
Purchases of property and equipment (71) (142)
Net cash provided by/(used in) investing activities 141 (503) Close
Financing activities    
Repayments of long-term borrowings (1,000) 0
Proceeds from long-term borrowings 2,979 1,238
Cash dividends paid (1,553) (1,544)
Proceeds from stock options exercised 163 27
Repurchases of common stock (1,153) (1,104)
Net proceeds from (repayments of) borrowings by CIPs 72 (23)
Net subscriptions received/(redemptions/distributions paid) from noncontrolling interest holders 955 640
Other financing activities (9) 12
Net cash provided by/(used in) financing activities 454 (754) Close
Effect of exchange rate changes on cash, cash equivalents and restricted cash (60) 84 Close
Net increase/(decrease) in cash, cash equivalents and restricted cash 1,492 (582) Close
Cash, cash equivalents and restricted cash, beginning of period 8,753 7,433
Cash, cash equivalents and restricted cash, end of period 10,245 6,851
Supplemental schedule of noncash investing and financing transactions:    
Issuance of common stock 417 524
Increase (decrease) in noncontrolling interests due to net consolidation (deconsolidation) of sponsored investment funds $ (803) $ (62)